1. Home
  2. BOLD vs MBBC Comparison

BOLD vs MBBC Comparison

Compare BOLD & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • MBBC
  • Stock Information
  • Founded
  • BOLD 2018
  • MBBC 1902
  • Country
  • BOLD United States
  • MBBC United States
  • Employees
  • BOLD N/A
  • MBBC N/A
  • Industry
  • BOLD
  • MBBC Banks
  • Sector
  • BOLD
  • MBBC Finance
  • Exchange
  • BOLD Nasdaq
  • MBBC Nasdaq
  • Market Cap
  • BOLD 33.4M
  • MBBC 31.7M
  • IPO Year
  • BOLD 2024
  • MBBC N/A
  • Fundamental
  • Price
  • BOLD $1.25
  • MBBC $10.80
  • Analyst Decision
  • BOLD Buy
  • MBBC
  • Analyst Count
  • BOLD 4
  • MBBC 0
  • Target Price
  • BOLD $4.00
  • MBBC N/A
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • MBBC 3.7K
  • Earning Date
  • BOLD 11-05-2025
  • MBBC 11-22-2025
  • Dividend Yield
  • BOLD N/A
  • MBBC N/A
  • EPS Growth
  • BOLD N/A
  • MBBC N/A
  • EPS
  • BOLD N/A
  • MBBC 0.02
  • Revenue
  • BOLD N/A
  • MBBC $6,885,334.00
  • Revenue This Year
  • BOLD N/A
  • MBBC N/A
  • Revenue Next Year
  • BOLD N/A
  • MBBC N/A
  • P/E Ratio
  • BOLD N/A
  • MBBC $747.74
  • Revenue Growth
  • BOLD N/A
  • MBBC 1.92
  • 52 Week Low
  • BOLD $1.00
  • MBBC $6.92
  • 52 Week High
  • BOLD $3.75
  • MBBC $12.89
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 40.98
  • MBBC 53.04
  • Support Level
  • BOLD $1.37
  • MBBC $10.64
  • Resistance Level
  • BOLD $1.52
  • MBBC $11.00
  • Average True Range (ATR)
  • BOLD 0.07
  • MBBC 0.13
  • MACD
  • BOLD -0.03
  • MBBC -0.02
  • Stochastic Oscillator
  • BOLD 6.25
  • MBBC 38.24

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

Share on Social Networks: